chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, Blood creatinine increased, Brain natriuretic peptide increased, COVID-19
Clinical narrative: Discharge Provider:  (name withheld) Primary Care Provider at Discharge: (name withheld) Admission Date: 6/22/2022 Discharge Date: 06/24/2022  PRESENTING PROBLEM: Paroxysmal atrial fibrillation   Systolic congestive heart failure, unspecified HF chronicity  COVID  COVID-19  Dyspnea   HOSPITAL COURSE:   77 y.o. male with past medical history significant for essential hypertension, sleep apnea, CKD, coronary artery disease, obesity who presented to the emergency department for increased shortness of breath.   Patient reports that approximately 4-5 days ago, he noticed that he started to have a dry cough, shortness of breath, orthopnea, and proximal nocturnal dyspnea as well as 5 lb of weight gain.  At home, he normally takes 60 mg of Lasix workup. He doubled the dose but this did not help.    In the ED the patient was hemodynamically stable and afebrile.  Initial lab work revealed creatinine 1.39, GFR 50, BNP 1829. Initial troponin 30, 2 hour repeat 33.  He did have a positive COVID test PCR test.  EKG showed new found atrial fibrillation with a rate of 70. Chest x-ray was negative for any acute findings.  He was given Lasix 100 mg IV and had adequate urine output of 700 mL.    He was admitted to Medicine in stable condition. His shortness of breath resolved. Cardiology was consulted and recommended transition back to home dose of lasix. He was started on eliquis and a limited ECHO was done. Patient was feeling quite well and discharged home in stable condition 6/24. ECHO results were pending and cardiology stated they would follow up outpatient
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Chest X-ray normal, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Discharge Provider:  (name withheld) Primary Care Provider at Discharge: (name withheld) Admission Date: 6/22/2022 Discharge Date: 06/24/2022  PRESENTING PROBLEM: Paroxysmal atrial fibrillation   Systolic congestive heart failure, unspecified HF chronicity  COVID  COVID-19  Dyspnea   HOSPITAL COURSE:   77 y.o. male with past medical history significant for essential hypertension, sleep apnea, CKD, coronary artery disease, obesity who presented to the emergency department for increased shortness of breath.   Patient reports that approximately 4-5 days ago, he noticed that he started to have a dry cough, shortness of breath, orthopnea, and proximal nocturnal dyspnea as well as 5 lb of weight gain.  At home, he normally takes 60 mg of Lasix workup. He doubled the dose but this did not help.    In the ED the patient was hemodynamically stable and afebrile.  Initial lab work revealed creatinine 1.39, GFR 50, BNP 1829. Initial troponin 30, 2 hour repeat 33.  He did have a positive COVID test PCR test.  EKG showed new found atrial fibrillation with a rate of 70. Chest x-ray was negative for any acute findings.  He was given Lasix 100 mg IV and had adequate urine output of 700 mL.    He was admitted to Medicine in stable condition. His shortness of breath resolved. Cardiology was consulted and recommended transition back to home dose of lasix. He was started on eliquis and a limited ECHO was done. Patient was feeling quite well and discharged home in stable condition 6/24. ECHO results were pending and cardiology stated they would follow up outpatient
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea paroxysmal nocturnal, Echocardiogram, Electrocardiogram abnormal, Glomerular filtration rate decreased, Left ventricular failure
Clinical narrative: Discharge Provider:  (name withheld) Primary Care Provider at Discharge: (name withheld) Admission Date: 6/22/2022 Discharge Date: 06/24/2022  PRESENTING PROBLEM: Paroxysmal atrial fibrillation   Systolic congestive heart failure, unspecified HF chronicity  COVID  COVID-19  Dyspnea   HOSPITAL COURSE:   77 y.o. male with past medical history significant for essential hypertension, sleep apnea, CKD, coronary artery disease, obesity who presented to the emergency department for increased shortness of breath.   Patient reports that approximately 4-5 days ago, he noticed that he started to have a dry cough, shortness of breath, orthopnea, and proximal nocturnal dyspnea as well as 5 lb of weight gain.  At home, he normally takes 60 mg of Lasix workup. He doubled the dose but this did not help.    In the ED the patient was hemodynamically stable and afebrile.  Initial lab work revealed creatinine 1.39, GFR 50, BNP 1829. Initial troponin 30, 2 hour repeat 33.  He did have a positive COVID test PCR test.  EKG showed new found atrial fibrillation with a rate of 70. Chest x-ray was negative for any acute findings.  He was given Lasix 100 mg IV and had adequate urine output of 700 mL.    He was admitted to Medicine in stable condition. His shortness of breath resolved. Cardiology was consulted and recommended transition back to home dose of lasix. He was started on eliquis and a limited ECHO was done. Patient was feeling quite well and discharged home in stable condition 6/24. ECHO results were pending and cardiology stated they would follow up outpatient
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Orthopnoea, SARS-CoV-2 test positive, Troponin, Weight increased
Clinical narrative: Discharge Provider:  (name withheld) Primary Care Provider at Discharge: (name withheld) Admission Date: 6/22/2022 Discharge Date: 06/24/2022  PRESENTING PROBLEM: Paroxysmal atrial fibrillation   Systolic congestive heart failure, unspecified HF chronicity  COVID  COVID-19  Dyspnea   HOSPITAL COURSE:   77 y.o. male with past medical history significant for essential hypertension, sleep apnea, CKD, coronary artery disease, obesity who presented to the emergency department for increased shortness of breath.   Patient reports that approximately 4-5 days ago, he noticed that he started to have a dry cough, shortness of breath, orthopnea, and proximal nocturnal dyspnea as well as 5 lb of weight gain.  At home, he normally takes 60 mg of Lasix workup. He doubled the dose but this did not help.    In the ED the patient was hemodynamically stable and afebrile.  Initial lab work revealed creatinine 1.39, GFR 50, BNP 1829. Initial troponin 30, 2 hour repeat 33.  He did have a positive COVID test PCR test.  EKG showed new found atrial fibrillation with a rate of 70. Chest x-ray was negative for any acute findings.  He was given Lasix 100 mg IV and had adequate urine output of 700 mL.    He was admitted to Medicine in stable condition. His shortness of breath resolved. Cardiology was consulted and recommended transition back to home dose of lasix. He was started on eliquis and a limited ECHO was done. Patient was feeling quite well and discharged home in stable condition 6/24. ECHO results were pending and cardiology stated they would follow up outpatient
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalization with covid; fully vaccinated
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Eye pain, Eye pruritus, Fatigue
Clinical narrative: On 6/14/2022, that evening, I noticed a few sneezes but that is not out of the norm for me because I have outdoor allergies. The next morning, I had a new patient appointment at noon with a gynecologist. I took a shower that morning and realized around 10AM that I did not feel well. So I took my temperature and it was slightly elevated at just under 100 degrees. I had a few at home COVID-19 tests, so I took one and the results were positive at which point I cancelled my appointment. Throughout that day, I began to feel progressively worse. The next few days, I felt terrible and was experiencing fever, body aches, headaches, extreme fatigue, and a cough. Leading up to these events, I had been on a trip about 10 days for an out door concert. I did however, ride in a car with 3 other people. Around 2 days after we returned, one of the people that travelled in the car with me, informed me that he was having COVID-19 like symptoms but tested negative for COVID-19 and positive for type 2 Flu and to my knowledge, no one in our group tested positive with the exception of me who tested positive around 10 days after we returned. The Sunday before I tested positive, I visited a exhibit with a friend and wore a mask, but none of the other patrons were wearing masks. We also visited a restaurant and maintained our mask wearing. After testing positive, I called my doctor's office and informed them of my positive results and to ask about a Paxlovid prescription. Within an hour, he called in a prescription for Paxlovid and a Cough medicine. I began taking those the same day that I tested positive. By day 3 my fever was gone and my body aches, headaches, and cough lessened but continued in a more mild capacity for a few more days. The following Monday, 6/20/2022, I took another at home COVID-19 test. The results were still positive, but the line was much lighter. The following Wednesday 06/22/22 I tested myself again and was negative. At this point, all of my symptoms have gotten better with the exception of noticeable fatigue after any activity and a slight cough. Although on Friday, 07/01/2022, I noticed some redness, achiness, and itchiness in my eyes that felt like an allergic reaction or pink eye. I emailed my doctor to inform him that I was using artificial tears and allergy medicine. He called in a prescription for an antibiotics which has helped.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Malaise, Ocular hyperaemia, Pain
Clinical narrative: On 6/14/2022, that evening, I noticed a few sneezes but that is not out of the norm for me because I have outdoor allergies. The next morning, I had a new patient appointment at noon with a gynecologist. I took a shower that morning and realized around 10AM that I did not feel well. So I took my temperature and it was slightly elevated at just under 100 degrees. I had a few at home COVID-19 tests, so I took one and the results were positive at which point I cancelled my appointment. Throughout that day, I began to feel progressively worse. The next few days, I felt terrible and was experiencing fever, body aches, headaches, extreme fatigue, and a cough. Leading up to these events, I had been on a trip about 10 days for an out door concert. I did however, ride in a car with 3 other people. Around 2 days after we returned, one of the people that travelled in the car with me, informed me that he was having COVID-19 like symptoms but tested negative for COVID-19 and positive for type 2 Flu and to my knowledge, no one in our group tested positive with the exception of me who tested positive around 10 days after we returned. The Sunday before I tested positive, I visited a exhibit with a friend and wore a mask, but none of the other patrons were wearing masks. We also visited a restaurant and maintained our mask wearing. After testing positive, I called my doctor's office and informed them of my positive results and to ask about a Paxlovid prescription. Within an hour, he called in a prescription for Paxlovid and a Cough medicine. I began taking those the same day that I tested positive. By day 3 my fever was gone and my body aches, headaches, and cough lessened but continued in a more mild capacity for a few more days. The following Monday, 6/20/2022, I took another at home COVID-19 test. The results were still positive, but the line was much lighter. The following Wednesday 06/22/22 I tested myself again and was negative. At this point, all of my symptoms have gotten better with the exception of noticeable fatigue after any activity and a slight cough. Although on Friday, 07/01/2022, I noticed some redness, achiness, and itchiness in my eyes that felt like an allergic reaction or pink eye. I emailed my doctor to inform him that I was using artificial tears and allergy medicine. He called in a prescription for an antibiotics which has helped.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sneezing
Clinical narrative: On 6/14/2022, that evening, I noticed a few sneezes but that is not out of the norm for me because I have outdoor allergies. The next morning, I had a new patient appointment at noon with a gynecologist. I took a shower that morning and realized around 10AM that I did not feel well. So I took my temperature and it was slightly elevated at just under 100 degrees. I had a few at home COVID-19 tests, so I took one and the results were positive at which point I cancelled my appointment. Throughout that day, I began to feel progressively worse. The next few days, I felt terrible and was experiencing fever, body aches, headaches, extreme fatigue, and a cough. Leading up to these events, I had been on a trip about 10 days for an out door concert. I did however, ride in a car with 3 other people. Around 2 days after we returned, one of the people that travelled in the car with me, informed me that he was having COVID-19 like symptoms but tested negative for COVID-19 and positive for type 2 Flu and to my knowledge, no one in our group tested positive with the exception of me who tested positive around 10 days after we returned. The Sunday before I tested positive, I visited a exhibit with a friend and wore a mask, but none of the other patrons were wearing masks. We also visited a restaurant and maintained our mask wearing. After testing positive, I called my doctor's office and informed them of my positive results and to ask about a Paxlovid prescription. Within an hour, he called in a prescription for Paxlovid and a Cough medicine. I began taking those the same day that I tested positive. By day 3 my fever was gone and my body aches, headaches, and cough lessened but continued in a more mild capacity for a few more days. The following Monday, 6/20/2022, I took another at home COVID-19 test. The results were still positive, but the line was much lighter. The following Wednesday 06/22/22 I tested myself again and was negative. At this point, all of my symptoms have gotten better with the exception of noticeable fatigue after any activity and a slight cough. Although on Friday, 07/01/2022, I noticed some redness, achiness, and itchiness in my eyes that felt like an allergic reaction or pink eye. I emailed my doctor to inform him that I was using artificial tears and allergy medicine. He called in a prescription for an antibiotics which has helped.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Laboratory test
Clinical narrative: NONE
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalization with covid; fully vaccinated
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Bacterial test positive, COVID-19, Caesarean section, Computerised tomogram abdomen abnormal
Clinical narrative: Admission Date: 6/21/2022 Discharge Date: 6/25/2022  ADMISSION DIAGNOSES: 1. Incisional hematoma   DISCHARGE DIAGNOSES 1. Status post incision and drainage 2. Incisional hematoma 3. Positive bacterial cultures 4. COVID 19 positive   CONDITION ON DISCHARGE: Good     PROCEDURES PERFORMED:  Evacuation of incisional hematoma   Hospital course Patient presented 6/21 as a 36 yo G3P1114 postoperative from primary cesarean secondary to triplet gestation with NRFHT with a chief complain of incisional bleeding. Patient medical history complicated by Factor V homozoygous. She was anticoagulated on  Lovenox 120 mg BID. She has history of DVT/PE and plan was for 6 weeks of anticoagulation. Incision began same evening, and she soaked through multiple pads at home. Evaluated in ED, admitted to L and D for monitoring of bleeding. Lovenox held. CT abdomen and pelvis demonstrated large subcutaneous hematoma. Liver hemangiomas were also noted. She was taken for I and D. Hematoma removed, necrotic tissue fused with hematoma was noted. Rectus/fascia intact. Wound vac placed. Started on zosyn, monitored on postpartum. Did well post operatively. Was mild symptomatic with respiratory symptoms, found COVID positive during stay. Discussed paxlovid for improvement of COVID symptoms and shortening duration of illness but unknown long term outcomes with breastfeeding, patient desired to start. Wound cultures grew out serratia and klebsiella. She was deescalated from zosyn to cipro. Discharged home in stable condition with instructions to start paxlovid and start PO cipro. Will continue on lovenox postpartum. Cultures resulted as sensitive to cipro, patient to continue. Stable at time of discharge. At time of discharge patient was ambulating, pain controlled, voiding, tolerating po intake, passing gas/flatus.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Culture wound positive, Haemangioma of liver, Haematoma evacuation, Incision site haematoma, Incision site haemorrhage
Clinical narrative: Admission Date: 6/21/2022 Discharge Date: 6/25/2022  ADMISSION DIAGNOSES: 1. Incisional hematoma   DISCHARGE DIAGNOSES 1. Status post incision and drainage 2. Incisional hematoma 3. Positive bacterial cultures 4. COVID 19 positive   CONDITION ON DISCHARGE: Good     PROCEDURES PERFORMED:  Evacuation of incisional hematoma   Hospital course Patient presented 6/21 as a 36 yo G3P1114 postoperative from primary cesarean secondary to triplet gestation with NRFHT with a chief complain of incisional bleeding. Patient medical history complicated by Factor V homozoygous. She was anticoagulated on  Lovenox 120 mg BID. She has history of DVT/PE and plan was for 6 weeks of anticoagulation. Incision began same evening, and she soaked through multiple pads at home. Evaluated in ED, admitted to L and D for monitoring of bleeding. Lovenox held. CT abdomen and pelvis demonstrated large subcutaneous hematoma. Liver hemangiomas were also noted. She was taken for I and D. Hematoma removed, necrotic tissue fused with hematoma was noted. Rectus/fascia intact. Wound vac placed. Started on zosyn, monitored on postpartum. Did well post operatively. Was mild symptomatic with respiratory symptoms, found COVID positive during stay. Discussed paxlovid for improvement of COVID symptoms and shortening duration of illness but unknown long term outcomes with breastfeeding, patient desired to start. Wound cultures grew out serratia and klebsiella. She was deescalated from zosyn to cipro. Discharged home in stable condition with instructions to start paxlovid and start PO cipro. Will continue on lovenox postpartum. Cultures resulted as sensitive to cipro, patient to continue. Stable at time of discharge. At time of discharge patient was ambulating, pain controlled, voiding, tolerating po intake, passing gas/flatus.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Incisional drainage, Klebsiella test positive, Multiple pregnancy, Nonreassuring foetal heart rate pattern, Respiratory symptom
Clinical narrative: Admission Date: 6/21/2022 Discharge Date: 6/25/2022  ADMISSION DIAGNOSES: 1. Incisional hematoma   DISCHARGE DIAGNOSES 1. Status post incision and drainage 2. Incisional hematoma 3. Positive bacterial cultures 4. COVID 19 positive   CONDITION ON DISCHARGE: Good     PROCEDURES PERFORMED:  Evacuation of incisional hematoma   Hospital course Patient presented 6/21 as a 36 yo G3P1114 postoperative from primary cesarean secondary to triplet gestation with NRFHT with a chief complain of incisional bleeding. Patient medical history complicated by Factor V homozoygous. She was anticoagulated on  Lovenox 120 mg BID. She has history of DVT/PE and plan was for 6 weeks of anticoagulation. Incision began same evening, and she soaked through multiple pads at home. Evaluated in ED, admitted to L and D for monitoring of bleeding. Lovenox held. CT abdomen and pelvis demonstrated large subcutaneous hematoma. Liver hemangiomas were also noted. She was taken for I and D. Hematoma removed, necrotic tissue fused with hematoma was noted. Rectus/fascia intact. Wound vac placed. Started on zosyn, monitored on postpartum. Did well post operatively. Was mild symptomatic with respiratory symptoms, found COVID positive during stay. Discussed paxlovid for improvement of COVID symptoms and shortening duration of illness but unknown long term outcomes with breastfeeding, patient desired to start. Wound cultures grew out serratia and klebsiella. She was deescalated from zosyn to cipro. Discharged home in stable condition with instructions to start paxlovid and start PO cipro. Will continue on lovenox postpartum. Cultures resulted as sensitive to cipro, patient to continue. Stable at time of discharge. At time of discharge patient was ambulating, pain controlled, voiding, tolerating po intake, passing gas/flatus.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serratia test positive, Soft tissue necrosis, Subcutaneous haematoma, Wound closure
Clinical narrative: Admission Date: 6/21/2022 Discharge Date: 6/25/2022  ADMISSION DIAGNOSES: 1. Incisional hematoma   DISCHARGE DIAGNOSES 1. Status post incision and drainage 2. Incisional hematoma 3. Positive bacterial cultures 4. COVID 19 positive   CONDITION ON DISCHARGE: Good     PROCEDURES PERFORMED:  Evacuation of incisional hematoma   Hospital course Patient presented 6/21 as a 36 yo G3P1114 postoperative from primary cesarean secondary to triplet gestation with NRFHT with a chief complain of incisional bleeding. Patient medical history complicated by Factor V homozoygous. She was anticoagulated on  Lovenox 120 mg BID. She has history of DVT/PE and plan was for 6 weeks of anticoagulation. Incision began same evening, and she soaked through multiple pads at home. Evaluated in ED, admitted to L and D for monitoring of bleeding. Lovenox held. CT abdomen and pelvis demonstrated large subcutaneous hematoma. Liver hemangiomas were also noted. She was taken for I and D. Hematoma removed, necrotic tissue fused with hematoma was noted. Rectus/fascia intact. Wound vac placed. Started on zosyn, monitored on postpartum. Did well post operatively. Was mild symptomatic with respiratory symptoms, found COVID positive during stay. Discussed paxlovid for improvement of COVID symptoms and shortening duration of illness but unknown long term outcomes with breastfeeding, patient desired to start. Wound cultures grew out serratia and klebsiella. She was deescalated from zosyn to cipro. Discharged home in stable condition with instructions to start paxlovid and start PO cipro. Will continue on lovenox postpartum. Cultures resulted as sensitive to cipro, patient to continue. Stable at time of discharge. At time of discharge patient was ambulating, pain controlled, voiding, tolerating po intake, passing gas/flatus.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Bone pain, Fatigue, Myalgia, Pain in extremity
Clinical narrative: SEVERE ARM SORENESS. MUSCLE & BONE ACHES ALL OVER BODY. EXHAUSTION,
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: Symptoms started 7/2/22 with a cough. Home positive test on 7/2/22. In house positive test on 7/5/22. Treatment includes admission with potential monoclonal antibodies.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Diarrhoea, Dizziness, Dyspnoea
Clinical narrative: Pfizer Dose 1 3/12/21 (EN6204) Pfizer Dose 2 4/14/21 (EW0153) COVID Positive 1/4/22  1/4/22: Patient is a 80 year old female with past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient does have a history of CVA and was admitted from September 1st until September 3rd of this year.  That time she was found to have a acute right frontal lobe ischemic infarct.  Patient states she has no residual deficits from that time.  She does take 81 mg of aspirin per day.  Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster.  Her daughter did test positive for COVID-19 today.  Patient did have some desaturations at rest as well as with exertion in the ER and is currently on 2 L.  She denies any chest pain or abdominal pain.  1/7/22: past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster. She had exposure to her daughter who is COVID positive. she was being managed with IV steroids, IV antibiotics and IV remdesivir on admission. Her symptoms improved decline in inflammatory markers but patient was on 2L oxygenation which seems to be the plateau. She had an oxygen walk test which showed she requires 3L with exertion and no oxygen at rest. Will discharged on covid supportive treatments, PO decadron and PO levofloxacin as well as COVID safe home program.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Inappropriate schedule of product administration, Inflammatory marker decreased, Ischaemic cerebral infarction, Malaise
Clinical narrative: Pfizer Dose 1 3/12/21 (EN6204) Pfizer Dose 2 4/14/21 (EW0153) COVID Positive 1/4/22  1/4/22: Patient is a 80 year old female with past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient does have a history of CVA and was admitted from September 1st until September 3rd of this year.  That time she was found to have a acute right frontal lobe ischemic infarct.  Patient states she has no residual deficits from that time.  She does take 81 mg of aspirin per day.  Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster.  Her daughter did test positive for COVID-19 today.  Patient did have some desaturations at rest as well as with exertion in the ER and is currently on 2 L.  She denies any chest pain or abdominal pain.  1/7/22: past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster. She had exposure to her daughter who is COVID positive. she was being managed with IV steroids, IV antibiotics and IV remdesivir on admission. Her symptoms improved decline in inflammatory markers but patient was on 2L oxygenation which seems to be the plateau. She had an oxygen walk test which showed she requires 3L with exertion and no oxygen at rest. Will discharged on covid supportive treatments, PO decadron and PO levofloxacin as well as COVID safe home program.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pain, Productive cough, Pyrexia, Vomiting
Clinical narrative: Pfizer Dose 1 3/12/21 (EN6204) Pfizer Dose 2 4/14/21 (EW0153) COVID Positive 1/4/22  1/4/22: Patient is a 80 year old female with past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient does have a history of CVA and was admitted from September 1st until September 3rd of this year.  That time she was found to have a acute right frontal lobe ischemic infarct.  Patient states she has no residual deficits from that time.  She does take 81 mg of aspirin per day.  Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster.  Her daughter did test positive for COVID-19 today.  Patient did have some desaturations at rest as well as with exertion in the ER and is currently on 2 L.  She denies any chest pain or abdominal pain.  1/7/22: past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster. She had exposure to her daughter who is COVID positive. she was being managed with IV steroids, IV antibiotics and IV remdesivir on admission. Her symptoms improved decline in inflammatory markers but patient was on 2L oxygenation which seems to be the plateau. She had an oxygen walk test which showed she requires 3L with exertion and no oxygen at rest. Will discharged on covid supportive treatments, PO decadron and PO levofloxacin as well as COVID safe home program.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Walking distance test abnormal
Clinical narrative: Pfizer Dose 1 3/12/21 (EN6204) Pfizer Dose 2 4/14/21 (EW0153) COVID Positive 1/4/22  1/4/22: Patient is a 80 year old female with past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.  History is obtained from chart review as well as discussion with the patient and the ED provider.  Patient does have a history of CVA and was admitted from September 1st until September 3rd of this year.  That time she was found to have a acute right frontal lobe ischemic infarct.  Patient states she has no residual deficits from that time.  She does take 81 mg of aspirin per day.  Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster.  Her daughter did test positive for COVID-19 today.  Patient did have some desaturations at rest as well as with exertion in the ER and is currently on 2 L.  She denies any chest pain or abdominal pain.  1/7/22: past history of CVA, hypertension, hyperlipidemia, and GERD who was admitted with shortness of breath, cough, diarrhea and found to have partial hypoxemia.Patient started feeling ill about 3 weeks ago.  She has had worsening shortness of breath as well as sputum production which she described as being pain.  Does get more short of breath when she tries to lie flat.  She has had some fevers and chills as well as vomiting and diarrhea.  Also having dizziness with walking.  She has had 2 COVID-19 shots but no booster. She had exposure to her daughter who is COVID positive. she was being managed with IV steroids, IV antibiotics and IV remdesivir on admission. Her symptoms improved decline in inflammatory markers but patient was on 2L oxygenation which seems to be the plateau. She had an oxygen walk test which showed she requires 3L with exertion and no oxygen at rest. Will discharged on covid supportive treatments, PO decadron and PO levofloxacin as well as COVID safe home program.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness
Clinical narrative: WEAKNESS OF LOWER EXTREMITIES
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Pyrexia
Clinical narrative: Sore injection site Chills Headache Fatigue Low Grade Fever 99.9F
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea
Clinical narrative: Developed diarrhea without blood or mucus. No N/V. Slightly decreased appetite, no significant cramping. Improving with OTC loperamide started on 7/4.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exercise tolerance decreased, Exposure to SARS-CoV-2, Fatigue, Malaise
Clinical narrative: COVID-19 symptoms started 06/17/22; tested positive 06/17/22. I had mild congestion and fairly significant fatigue. The congestion was for 4 days and the fatigue was for 4 days and persisted for 10 days. I was exposed and got Covid and we flew home and driving from from airport that night I started having symptoms. We stopped and got home tests and a number of us from the trip were positive. I still feel a bit tired but I am working. I also took Paxlovid starting the 18th. I still don't have the endurance like I did before.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: COVID-19 symptoms started 06/17/22; tested positive 06/17/22. I had mild congestion and fairly significant fatigue. The congestion was for 4 days and the fatigue was for 4 days and persisted for 10 days. I was exposed and got Covid and we flew home and driving from from airport that night I started having symptoms. We stopped and got home tests and a number of us from the trip were positive. I still feel a bit tired but I am working. I also took Paxlovid starting the 18th. I still don't have the endurance like I did before.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood glucose increased, COVID-19 pneumonia, Cognitive disorder, Dyspnoea
Clinical narrative: Provider summary "This is a 67 y/o female with a past medical history significant for advanced MS who presented to the ED on 6/9/2022 for evaluation of acute weakness and dyspnea following exposure to her daughter who had tested positive for COVID.  She was found to be hypoxic in the ED.  The patient was admitted to the hospitalist service for COVID pneumonia with hypoxia. She had an uneventful hospitalization and when medically stable, the patient was discharged to Lakeland Health Watervliet for  acute inpatient rehabilitation of functional and cognitive deficits.   Symptoms related to these abovementioned conditions and events were well-controlled, and the patient was discharged medically stable and improved. There were no significant acute episodes that affected length of stay or tolerance to therapies.  Patient was noted to have elevated blood sugars and leukocytosis while on dexamethasone.  Blood sugars and WBCs improved when steroid course was completed, though blood sugars did not completely return to normal despite use of home glimepiride requiring continued use of Lantus and ISS.  Lantus was discontinued and patient started on Januvia in conjunction with home glimeperide.  Blood sugars appear to be well controlled.     The patient was also provided orthotics / durable medical equipment to ensure improved function and safety in the rehabilitation and home setting.   Occupational, Physical and Speech Language Pathology therapists and a Neuropsychologist were consulted for evaluation and treatment so as to best determine the amount and extent of services required for cognitive and functional optimization. The patient received a minimum of 180 minutes of therapy per day for 5 out of 7 days, or more than 15 hours of intensive therapy over the course of a week.    While in the unit, the acute rehabilitation service also held interdisciplinary team conferences on a weekly basis to establish specific short- and long-term goals during rehabilitation, and for discharge. Barriers to discharge were also noted and updated as they were addressed. Plans to assure continuity and coordination of care after discharge from the acute rehabilitation unit were also established and explained to the patient and care provider(s).   While on the unit, the patient was monitored on a daily basis by a physician who evaluated and managed co-morbidities and medical conditions, as necessary.  Noteworthy events related to the patient's rehabilitative stay included the below mentioned - which were treated as indicated."
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Exposure to SARS-CoV-2, Hypoxia, Leukocytosis, Multimorbidity, White blood cell count increased
Clinical narrative: Provider summary "This is a 67 y/o female with a past medical history significant for advanced MS who presented to the ED on 6/9/2022 for evaluation of acute weakness and dyspnea following exposure to her daughter who had tested positive for COVID.  She was found to be hypoxic in the ED.  The patient was admitted to the hospitalist service for COVID pneumonia with hypoxia. She had an uneventful hospitalization and when medically stable, the patient was discharged to Lakeland Health Watervliet for  acute inpatient rehabilitation of functional and cognitive deficits.   Symptoms related to these abovementioned conditions and events were well-controlled, and the patient was discharged medically stable and improved. There were no significant acute episodes that affected length of stay or tolerance to therapies.  Patient was noted to have elevated blood sugars and leukocytosis while on dexamethasone.  Blood sugars and WBCs improved when steroid course was completed, though blood sugars did not completely return to normal despite use of home glimepiride requiring continued use of Lantus and ISS.  Lantus was discontinued and patient started on Januvia in conjunction with home glimeperide.  Blood sugars appear to be well controlled.     The patient was also provided orthotics / durable medical equipment to ensure improved function and safety in the rehabilitation and home setting.   Occupational, Physical and Speech Language Pathology therapists and a Neuropsychologist were consulted for evaluation and treatment so as to best determine the amount and extent of services required for cognitive and functional optimization. The patient received a minimum of 180 minutes of therapy per day for 5 out of 7 days, or more than 15 hours of intensive therapy over the course of a week.    While in the unit, the acute rehabilitation service also held interdisciplinary team conferences on a weekly basis to establish specific short- and long-term goals during rehabilitation, and for discharge. Barriers to discharge were also noted and updated as they were addressed. Plans to assure continuity and coordination of care after discharge from the acute rehabilitation unit were also established and explained to the patient and care provider(s).   While on the unit, the patient was monitored on a daily basis by a physician who evaluated and managed co-morbidities and medical conditions, as necessary.  Noteworthy events related to the patient's rehabilitative stay included the below mentioned - which were treated as indicated."
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold
Clinical narrative: The next day I felt very cold and fatigued for 2 days.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood alkaline phosphatase increased, Blood creatinine increased, Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia
Clinical narrative: Provider Summary "78-year-old female with history of HFrEF, dm 2, CKD 3, HLD, coronary artery disease with history of MI and CABG in 2019, PAF on Eliquis admitted for sepsis found to be secondary to COVID pneumonia as well as urinary tract infection.  Sepsis quickly resolved and patient found to have ESBL E coli for which patient received full 3 day course of ertapenem.  Patient did have some encephalopathy on admission which resolved likely secondary to urinary tract infection. Patient however treated for hypoxia with steroids and remdesivir in by time of discharge had been weaned off of supplemental oxygen (2 L) back to her baseline of room air for least 24 hours prior to discharge.  Noted the patient did have worsening creatinine up to 1.9 (baseline 1.6) during hospitalization for which patient's home Bumex had been temporarily held although restarted as could be cardiorenal as patient was developing 1 to 2+ edema half way up to the knees bilaterally.  Patient discharged with 3 more days of dexamethasone to complete 10 day course and continue on Tessalon although patient's cough much improved by time of discharge.  No other changes made to patient's medications."
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac failure acute, Cardiac failure congestive, Cardiomegaly, Chest pain, Condition aggravated
Clinical narrative: Provider Summary "78-year-old female with history of HFrEF, dm 2, CKD 3, HLD, coronary artery disease with history of MI and CABG in 2019, PAF on Eliquis admitted for sepsis found to be secondary to COVID pneumonia as well as urinary tract infection.  Sepsis quickly resolved and patient found to have ESBL E coli for which patient received full 3 day course of ertapenem.  Patient did have some encephalopathy on admission which resolved likely secondary to urinary tract infection. Patient however treated for hypoxia with steroids and remdesivir in by time of discharge had been weaned off of supplemental oxygen (2 L) back to her baseline of room air for least 24 hours prior to discharge.  Noted the patient did have worsening creatinine up to 1.9 (baseline 1.6) during hospitalization for which patient's home Bumex had been temporarily held although restarted as could be cardiorenal as patient was developing 1 to 2+ edema half way up to the knees bilaterally.  Patient discharged with 3 more days of dexamethasone to complete 10 day course and continue on Tessalon although patient's cough much improved by time of discharge.  No other changes made to patient's medications."
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Encephalopathy, Escherichia infection, Hypoxia, Left ventricular failure
Clinical narrative: Provider Summary "78-year-old female with history of HFrEF, dm 2, CKD 3, HLD, coronary artery disease with history of MI and CABG in 2019, PAF on Eliquis admitted for sepsis found to be secondary to COVID pneumonia as well as urinary tract infection.  Sepsis quickly resolved and patient found to have ESBL E coli for which patient received full 3 day course of ertapenem.  Patient did have some encephalopathy on admission which resolved likely secondary to urinary tract infection. Patient however treated for hypoxia with steroids and remdesivir in by time of discharge had been weaned off of supplemental oxygen (2 L) back to her baseline of room air for least 24 hours prior to discharge.  Noted the patient did have worsening creatinine up to 1.9 (baseline 1.6) during hospitalization for which patient's home Bumex had been temporarily held although restarted as could be cardiorenal as patient was developing 1 to 2+ edema half way up to the knees bilaterally.  Patient discharged with 3 more days of dexamethasone to complete 10 day course and continue on Tessalon although patient's cough much improved by time of discharge.  No other changes made to patient's medications."
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lung disorder, Oedema peripheral, Pathogen resistance, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Provider Summary "78-year-old female with history of HFrEF, dm 2, CKD 3, HLD, coronary artery disease with history of MI and CABG in 2019, PAF on Eliquis admitted for sepsis found to be secondary to COVID pneumonia as well as urinary tract infection.  Sepsis quickly resolved and patient found to have ESBL E coli for which patient received full 3 day course of ertapenem.  Patient did have some encephalopathy on admission which resolved likely secondary to urinary tract infection. Patient however treated for hypoxia with steroids and remdesivir in by time of discharge had been weaned off of supplemental oxygen (2 L) back to her baseline of room air for least 24 hours prior to discharge.  Noted the patient did have worsening creatinine up to 1.9 (baseline 1.6) during hospitalization for which patient's home Bumex had been temporarily held although restarted as could be cardiorenal as patient was developing 1 to 2+ edema half way up to the knees bilaterally.  Patient discharged with 3 more days of dexamethasone to complete 10 day course and continue on Tessalon although patient's cough much improved by time of discharge.  No other changes made to patient's medications."
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary incontinence, Urinary tract infection
Clinical narrative: Provider Summary "78-year-old female with history of HFrEF, dm 2, CKD 3, HLD, coronary artery disease with history of MI and CABG in 2019, PAF on Eliquis admitted for sepsis found to be secondary to COVID pneumonia as well as urinary tract infection.  Sepsis quickly resolved and patient found to have ESBL E coli for which patient received full 3 day course of ertapenem.  Patient did have some encephalopathy on admission which resolved likely secondary to urinary tract infection. Patient however treated for hypoxia with steroids and remdesivir in by time of discharge had been weaned off of supplemental oxygen (2 L) back to her baseline of room air for least 24 hours prior to discharge.  Noted the patient did have worsening creatinine up to 1.9 (baseline 1.6) during hospitalization for which patient's home Bumex had been temporarily held although restarted as could be cardiorenal as patient was developing 1 to 2+ edema half way up to the knees bilaterally.  Patient discharged with 3 more days of dexamethasone to complete 10 day course and continue on Tessalon although patient's cough much improved by time of discharge.  No other changes made to patient's medications."
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Lethargy
Clinical narrative: My wife  got COVID-19 and I picked it up from here.  I began to feel tired and lethargic with congestion and nose running.  Also, had a slight cough.  I tested positive on 6/23/22.  We contacted our doctor and was put on paxlovid which we took for 5 days.  As of now we have tested negative.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: My wife  got COVID-19 and I picked it up from here.  I began to feel tired and lethargic with congestion and nose running.  Also, had a slight cough.  I tested positive on 6/23/22.  We contacted our doctor and was put on paxlovid which we took for 5 days.  As of now we have tested negative.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was administered the Pfizer vaccine after the Beyond Use Date of 5/10/2022.   The patient had no other adverse events.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated